Wellgistics Health Invests in Mental Health AI Startup

Got story updates? Submit your updates here. ›

Wellgistics Health, a health information technology leader, has completed a strategic investment in a San Francisco-based mental health AI startup. The investment is part of Wellgistics' focus on patient engagement to improve prescription drug compliance, promote complementary healthcare products, and further integrate its pharmacy network as touchpoints for additional services and support.

Why it matters

The mental health software market is expected to grow significantly in the coming years, driven by the increasing adoption of digital healthcare platforms and software-based treatments. By investing in a mental health AI startup, Wellgistics aims to leverage this trend and provide unique support for patients, especially those initiating GLP-1 drug treatment.

The details

Wellgistics is integrating its proprietary pharmacy dispensing optimization AI platform EinsteinRx and blockchain-enabled smart contracts platform PharmacyChain to optimize the prescription drug dispensing journey. The investment in the mental health AI startup will help drive Wellgistics' partnership with Tollo Health's TolloCare subsidiary, which provides a telehealth service offering. The goal is to promote patient engagement, compliance, and lifestyle changes through the use of mental health AI software.

• Wellgistics announced the partnership with Tollo Health's TolloCare subsidiary previously.
• Wellgistics has completed the strategic investment in the San Francisco-based mental health AI startup on February 18, 2026.

What’s next

Wellgistics aims to further integrate its pharmacy network as touchpoints to provide additional products, services and support for patients, especially those initiating GLP-1 drug treatment.